161 related articles for article (PubMed ID: 11703341)
1. Protamine inhibits tissue factor-initiated extrinsic coagulation.
Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
[TBL] [Abstract][Full Text] [Related]
2. Novel anticoagulant activity of polybrene: inhibition of monocytic tissue factor hypercoagulation following bacterial endotoxin induction.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):123-8. PubMed ID: 11914654
[TBL] [Abstract][Full Text] [Related]
3. Novel anticoagulant activity of polyamino acid offsets bacterial endotoxin-induced extrinsic hypercoagulation: downregulation of monocytic tissue factor-dependent FVII activation.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
J Cardiovasc Pharmacol; 2003 Oct; 42(4):477-83. PubMed ID: 14508232
[TBL] [Abstract][Full Text] [Related]
4. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
5. Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin.
Chu AJ; Raphael UO; Prasad JK; Beydoun S; Ramos N
J Surg Res; 1999 Dec; 87(2):252-7. PubMed ID: 10600357
[TBL] [Abstract][Full Text] [Related]
6. Blockade by ruthenium red of tissue factor-initiated coagulation.
Chu AJ; Wang ZG; Nwobi OI; Beydoun S
Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptide buforin I inhibits tissue factor-initiated coagulation.
Chu AJ; Chen BM; Lin H; Beydoun S
Arch Biochem Biophys; 2001 Aug; 392(1):3-7. PubMed ID: 11469787
[TBL] [Abstract][Full Text] [Related]
8. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
Chu AJ; Wang ZG; Raphael UO
J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
[TBL] [Abstract][Full Text] [Related]
9. Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
Chu AJ
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):13-8. PubMed ID: 21184651
[TBL] [Abstract][Full Text] [Related]
10. Possible role of Marcks in the cellular modulation of monocytic tissue factor-initiated hypercoagulation.
Chu AJ; Lin SH; Piasentin E
Br J Haematol; 2002 Aug; 118(2):569-76. PubMed ID: 12139748
[TBL] [Abstract][Full Text] [Related]
11. Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation.
Chu AJ; Beydoun S; Mathews ST; Hoang J
Arch Biochem Biophys; 2003 Jul; 415(1):101-8. PubMed ID: 12801518
[TBL] [Abstract][Full Text] [Related]
12. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
13. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
Pernerstorfer T; Stohlawetz P; Hollenstein U; Dzirlo L; Eichler HG; Kapiotis S; Jilma B; Speiser W
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2517-23. PubMed ID: 10521382
[TBL] [Abstract][Full Text] [Related]
16. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
[TBL] [Abstract][Full Text] [Related]
17. Heparin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
[TBL] [Abstract][Full Text] [Related]
18. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
[TBL] [Abstract][Full Text] [Related]
19. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood.
Barstad RM; Hamers MJ; Kierulf P; Westvik AB; Sakariassen KS
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):11-6. PubMed ID: 7749805
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant potential of an antibody against factor VII.
Chu AJ; Mathews ST
J Surg Res; 2003 Sep; 114(1):37-41. PubMed ID: 13678696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
